The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase

Journal of Virology

Volumn 77, Issue 14, 2003, Pages 7720-7727

  Krosky, Paula M ^a,c   Baek, Moon Chang ^a,d   Jahng, Wan Jin ^a   Barrera, Imma ^b,e   Harvey, Robert J ^b   Biron, Karen K ^b   Coen, Donald M ^a   Sethna, Phiroze B ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GLAXOSMITHKLINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAVIR; PROTEIN KINASE; PROTEIN UL44; PROTEIN UL97; RECOMBINANT PROTEIN; SERINE; THREONINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL LYSATE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOPRECIPITATION; ISOTOPE LABELING; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BACULOVIRIDAE; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA-BINDING PROTEINS; HUMANS; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PRECIPITIN TESTS; RECOMBINANT FUSION PROTEINS; SPODOPTERA; SUBSTRATE SPECIFICITY; VIRAL PROTEINS;

EID: 0038082392     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.14.7720-7727.2003     Document Type: Article

References (35)

1. Baek, M.-C., P. M. Krosky, and D. M. Coen. 2002. The relationship between autophosphorylation and phosphorylation of exogenous substrates by the human cytomegalovirus UL97 protein kinase. J. Virol. 76:11943-11952.
2. Baek, M.-C., P. M. Krosky, Z. He, and D. M. Coen. 2002. Specific phosphorylation of exogenous protein and peptide substrates by the human cytomegalovirus UL97 protein kinase: importance of the P+5 position. J. Biol. Chem. 277:29593-29599.
3. Biron, K. K., R. J. Harvey, S. C. Chamberlain, S. S. Good, A. A. Smith, M. G. Davis, C. L. Talarico, R. Ferris, R. E. Dornsife, S. C. Stanat, J. C. Drach, L. B. Townsend, and G. W. Koszalka. 2002. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob. Agents Chemother. 46:2365-2372.
4. Boccuni, M. C., F. Campanini, M. C. Battista, G. Bergamini, P. Dal Monte, A. Ripalti, and M. P. Landini. 1998. Human cytomegalovirus product UL44 downregulates the transactivation of HIV-1 long terminal repeats. AIDS. 12:365-372.
5. Chee, M., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchinson III, T. Kouzarides, J. A. Martignetti, E. Preddie, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immun. 154:125-169.
6. Chee, M. S., G. L. Lawrence, and B. G. Barrell. 1989. Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J. Gen. Virol. 70:1151-1160.
7. Chen, M.-R., S.-J. Chang, H. Huang, and J.-Y. Chen. 2000. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J. Virol. 74:3093-3104.
8. Coen, D. M., and Z. He. June 1999. UL97 fusion proteins and methods of use. U.S. patent 5,914,244.
9. Crossen, R., and S. Gruenwald. 1998. Baculovirus expression vector system manual, 5th ed. Pharmingen, San Diego, Calif.
10. Ertl, P. F., and K. L. Powell. 1992. Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells. J. Virol. 66:4126-4133.
11. Gibson, W., T. L. Murphy, and C. Roby. 1981. Cytomegalovirus-infected cells contain a DNA binding protein. Virology 111:251-262.
12. Hanks, S. K., and T. Hunter. 1995. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9:576-596.
13. He, Z., Y.-S. He, Y. Kim, L. Chu, C. Ohmstede, K. K. Biron, and D. M. Coen. 1997. The human cytomegalovirus UL97 protein is a protein kinase that phosphorylates on serines and threonines. J. Virol. 71:405-411.
14. Kenyon,T. K., J. Lynch, J. Hay, W. Ruyechan, and C. Grose. 2001. Varicellazoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J. Virol. 75:8854-8858.
15. Krosky, P. M., M. C. Baek, and D. M. Coen. 2003. Human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 77:905-914.
16. Leach, F. S., and E. S. Mocarski. 1989. Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J. Virol. 63:1783-1791.
17. Littler, E., A. D. Stuart, and M. S. Chee. 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358:160-162.
18. McGeoch, D. J., L. J. Coulter, and H. W. M. Moss. 1995. UL protein kinases (herpesviruses), p. 391-393. In D. G. Hardie and S. Hanks (ed.), The protein kinase facts book, vol. 1. Academic Press, London, United Kingdom.
19. Ng, T. I., L. Keenan, P. R. Kinchington, and C. Grose. 1994. Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J. Virol. 68:1350-1359.
20. Ng, T. I., W. O. Ogle, and B. Roizman. 1998. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I. Virology 241:37-48.
21. Ng, T. I., C. Talarico, T. C. Burnette, K. Biron, and B. Roizman. 1996. Partial substitution of the functions of the herpes simplex virus UL13 gene by the human cytomegalovirus UL97 gene. Virology 225:347-358.
22. Ogle, W. O., T. I. Ng, K. L. Carter, and B. Roizman. 1997. The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0. Virology 235:406-413.
23. Pari, G. S., and D. G. Anders. 1993. Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J. Virol. 67:6979-6988.
24. Pari, G. S., M. A. Kacica, and D. G. Anders. 1993. Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. J. Virol. 67:2575-2582.
25. Prichard, M. N., N. Gao, S. Jairath, G. Mulamba, P. Krosky, D. M. Coen, B. O. Parker, and G. S. Pari. 1999. A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J. Virol. 73:5663-5670.
26. Purves, F. C., W. O. Ogle, and B. Roizman. 1993. Processing of the herpes simplex virus regulatory protein α22 mediated by the UL13 protein kinase determines the accumulation of a subset of αand γ mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. USA 90:6701-6705.
27. Reddy, S. M., E. Cox, I. Iofin, W. Soong, and J. I. Cohen. 1998. Varicellazoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J. Virol. 72:8083-8088.
28. Ripalti, A., M. C. Boccuni, F. Campanini, and M. P. Landini. 1995. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J. Virol. 69:2047-2057.
29. Sullivan, V., C. L. Talarico, S. C. Stanat, M. Davis, D. M. Coen, and K. K. Biron. 1992. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 358:162-164.
30. Talarico, C. L., T. C. Burnette, W. H. Miller, S. L. Smith, M. G. Davis, S. C. Stanat, T. I. Ng, Z. He, D. M. Coen, B. Roizman, and K. K. Biron. 1999. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein. Antimicrob. Agents Chemother. 43:1941-1946.
31. Turk, S. R., C. Shipman, Jr., R. Nassiri, G. Genzlinger, S. H. Krawczyk, L. B. Townsend, and J. C. Drach. 1987. Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirus. Antimicrob. Agents Chemother. 31:544-550.
32. Weiland, K. L., N. L. Oien, F. Homa, and M. W. Wathen. 1994. Functional analysis of human cytomegalovirus polymerase accessory protein. Virus Res. 34:191-206.
33. Wolf, D. G., C. T. Courcelle, M. N. Prichard, and E. S. Mocarski. 2001. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc. Natl. Acad. Sci. USA 98:1895-1900.
34. Zhang, Q., Y. Hong, D. Dorsky, E. Holley-Guthrie, S. Zalani, N. A. Elshiekh, A. Kiehl, T. Le, and S. Kenney. 1996. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: effects on EBV transcription and lytic replication. J. Virol. 70:5131-5142.
35. Zuccola, H. Z., D. J. Filman, D. M. Coen, and J. M. Hogle. 2000. The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase. Mol. Cell 5:267-278.